Natera, Inc. (NTRA) compared with its closest peers (RDNT, FTRE, GH, LMRI, CAI). Peer set by Healthcare Services; 10 comparable companies. First-party data.
RadNet, Fortrea, Guardant Health, Lumexa Imaging Holdings, Inc. Common Stock, Caris Life Sciences, Veracyte, Quest Diagnostics, Labcorp, CareDx and Castle Biosciences share Natera's sub-industry, medical laboratories.
| Company | Market Cap | P/E |
|---|---|---|
| RadNet, Inc. (RDNT) | $6.05B | -285.0 |
| Fortrea Holdings Inc. (FTRE) | $1.74B | -1.6 |
| Guardant Health, Inc. (GH) | $22.13B | -30.8 |
| Lumexa Imaging Holdings, Inc. Common Stock (LMRI) | $1.13B | 656.4 |
| Caris Life Sciences, Inc. (CAI) | $7.91B | -8.4 |
| Veracyte, Inc. (VCYT) | $3.52B | 30.7 |
| Quest Diagnostics Incorporated (DGX) | $26.99B | 25.4 |
| Labcorp Holdings Inc. (LH) | $27.39B | 24.6 |
| CareDx, Inc (CDNA) | $2.63B | 22.3 |
| Castle Biosciences, Inc. (CSTL) | $1.07B | -46.9 |
| Sector P/E (Healthcare) | 21.9 |
| Industry P/E (Healthcare Services) | 25.4 |
NTRA overview · NTRA earnings · NTRA financials · NTRA KPIs · NTRA documents · NTRA ownership
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.